This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Setting
The practice setting was a headache clinic at a tertiary care hospital in the USA.
Dates to which data relate
Effectiveness and resource use data were obtained between 1992-95 (approximately); data for the intervention were from an 18 month period following the start of the intervention in 1993; data for the control were from the 18 months immediately prior to the introduction of the intervention. The price year was not clearly stated.
Source of effectiveness data
The estimate for final outcome was derived from a single study.
Link between effectiveness and cost data
Costing was undertaken retrospectively on the same patient sample as that used in the effectiveness study.
Study sample
A consecutive sample of 104 patients attending a headache clinic (86% of those originally eligible) were chosen for analysis. Those attending the clinic once over an 18 month period prior to selection or those for whom sumatriptan was contraindicated were excluded. No power calculations were reported.
